NRX Pharmaceuticals (NRXP) Income Statement (2018 - 2026)
Income Statement report data from Mar 31, 2018 to Mar 31, 2026 for NRX Pharmaceuticals (NRXP).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||
Total Revenue | 1.07M (+9.18%) | 980K (+308.33%) | 240K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost Of Revenue | 630K (+53.66%) | 410K (+310.00%) | 100K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | 630K (+53.66%) | 410K (+310.00%) | 100K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 440K (-22.81%) | 570K (+307.14%) | 140K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 1.31M (+133.93%) | 560K (-60.84%) | 1.43M (+44.44%) | 990K (+23.75%) | 800K (-23.08%) | 1.04M (+70.49%) | 610K (-78.21%) | 2.80M (+60.00%) | 1.75M (-67.47%) | 5.38M (+62.54%) | 3.31M (-14.47%) | 3.87M (+383.75%) | 800K (-82.06%) | 4.46M (+7.99%) | 4.13M (+39.53%) | 2.96M (-45.99%) | 5.48M (-12.74%) | 6.28M (+45.03%) | 4.33M (+211.51%) | 1.39M | - | - | - | - | - | - | - | - | - |
Selling General And Administrative | 3.81M (-16.63%) | 4.57M (+62.63%) | 2.81M (+2.55%) | 2.74M (-6.80%) | 2.94M (+13.08%) | 2.60M (+7.88%) | 2.41M (-43.29%) | 4.25M (0.00%) | 4.25M (-9.77%) | 4.71M (+89.16%) | 2.49M (-38.82%) | 4.07M (+38.44%) | 2.94M (-45.86%) | 5.43M (+8.38%) | 5.01M (-24.55%) | 6.64M (-35.03%) | 10M (-26.05%) | 14M (+268.53%) | 3.75M (+607.55%) | 530K | - | - | - | - | - | - | - | - | - |
Operating Expenses | 5.81M (+3.57%) | 5.61M (+31.38%) | 4.27M (+14.48%) | 3.73M (-3.12%) | 3.85M (+58.44%) | 2.43M (-19.54%) | 3.02M (-57.16%) | 7.05M (+17.50%) | 6.00M (-39.94%) | 9.99M (+71.94%) | 5.81M (-29.06%) | 8.19M (+112.73%) | 3.85M (-61.07%) | 9.89M (+8.21%) | 9.14M (-4.79%) | 9.60M (-38.89%) | 16M (-21.84%) | 20M (+11723.53%) | 170K (-5.56%) | 180K (+50.00%) | 120K (-36.84%) | 190K (+5.56%) | 180K (0.00%) | 180K (+12.50%) | 160K (-50.00%) | 320K (+45.45%) | 220K (-18.52%) | 270K (+42.11%) | 190K |
Depreciation And Amortization | 60K (+50.00%) | 40K (+33.33%) | 30K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -4.74M (+2.60%) | -4.62M (+14.93%) | -4.02M (+7.77%) | -3.73M (-3.12%) | -3.85M (+58.44%) | -2.43M (-19.54%) | -3.02M (-57.16%) | -7.05M (+17.50%) | -6.00M (-39.94%) | -9.99M (+71.94%) | -5.81M (-29.06%) | -8.19M (+112.73%) | -3.85M (-61.07%) | -9.89M (+8.21%) | -9.14M (-4.79%) | -9.60M (-38.85%) | -15.70M (-21.89%) | -20.10M (+11723.53%) | -170.00K (-5.56%) | -180.00K (+50.00%) | -120.00K (-36.84%) | -190.00K (+5.56%) | -180.00K (0.00%) | -180.00K (+12.50%) | -160.00K (-50.00%) | -320.00K (+45.45%) | -220.00K (-18.52%) | -270.00K (+42.11%) | -190.00K |
Ebit | -4.74M (+2.60%) | -4.62M (+14.93%) | -4.02M (+7.77%) | -3.73M (-3.12%) | -3.85M (+58.44%) | -2.43M (-19.54%) | -3.02M (-57.16%) | -7.05M (+17.50%) | -6.00M (-39.94%) | -9.99M (+71.94%) | -5.81M (-29.06%) | -8.19M (+112.73%) | -3.85M (-61.07%) | -9.89M (+8.21%) | -9.14M (-4.79%) | -9.60M (-38.85%) | -15.70M (-21.89%) | -20.10M (+11723.53%) | -170.00K (-5.56%) | -180.00K (+50.00%) | -120.00K (-36.84%) | -190.00K (+5.56%) | -180.00K (0.00%) | -180.00K (+12.50%) | -160.00K (-50.00%) | -320.00K (+45.45%) | -220.00K (-18.52%) | -270.00K (+42.11%) | -190.00K |
EBITDA | -4.68M | 9.27M | -4.00M (-77.25%) | -17.58M (+356.62%) | -3.85M (+143.67%) | -1.58M (-47.68%) | -3.02M (-61.77%) | -7.90M (+31.67%) | -6.00M (-35.14%) | -9.25M (+53.65%) | -6.02M (-30.96%) | -8.72M (+126.49%) | -3.85M (-69.35%) | -12.56M (+38.33%) | -9.08M (+30.09%) | -6.98M (-55.54%) | -15.70M (-57.61%) | -37.04M (+23050.00%) | -160.00K (+6.67%) | -150.00K | 350K | -20.00K | 70K (-68.18%) | 220K (0.00%) | 220K | - | 60K | - | 20K |
Other Income / Expenses | |||||||||||||||||||||||||||||
Interest Income | 10K | - | - | - | - | - | 10K (0.00%) | 10K (-66.67%) | 30K (-86.96%) | 230K (+91.67%) | 120K (-14.29%) | 140K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 230K (-65.67%) | 670K | - | - | - | - | - | - | 230K (+187.50%) | 80K (+100.00%) | 40K | - | - | - | - | - | - | 10K (0.00%) | 10K | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 10K | - | - | - | - | 230K (+2200.00%) | 10K (0.00%) | 10K | -200.00K | 150K (+87.50%) | 80K (-42.86%) | 140K | - | - | - | - | - | - | -10.00K | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | 3.31M | -12.40M (+563.10%) | -1.87M (-86.50%) | -13.85M (+734.34%) | -1.66M (-74.92%) | -6.62M | 1.40M | -850.00K (+60.38%) | -530.00K (-77.06%) | -2.31M (+824.00%) | -250.00K (-52.83%) | -530.00K (-68.07%) | -1.66M | 4.58M (+7533.33%) | 60K (-97.71%) | 2.62M (+15.93%) | 2.26M | -16.95M | - | 30K (-93.62%) | 470K (-61.16%) | 1.21M (+365.38%) | 260K (-33.33%) | 390K (+2.63%) | 380K (-65.14%) | 1.09M (+289.29%) | 280K (+3.70%) | 270K (+28.57%) | 210K |
Net Income | |||||||||||||||||||||||||||||
Income Before Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | -39.75M | - | - | - | -20.77M (+12117.65%) | -170.00K (+6.25%) | -160.00K | 350K | -20.00K | 70K (-68.18%) | 220K (0.00%) | 220K | - | 60K | - | 20K |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -40.00K (+300.00%) | -10.00K | 70K | - | 20K (-50.00%) | 40K (+33.33%) | 30K | -30.00K | 30K (+200.00%) | 10K | - |
Net Income From Continuing Operations | -1.43M | 360K | -5.89M (-66.50%) | -17.58M (+219.06%) | -5.51M (-39.32%) | -9.08M (+460.49%) | -1.62M (-79.49%) | -7.90M (+20.98%) | -6.53M (-33.77%) | -9.86M (+62.71%) | -6.06M (-30.50%) | -8.72M (+58.26%) | -5.51M (-46.19%) | -10.24M (+12.78%) | -9.08M (+30.09%) | -6.98M (-48.10%) | -13.45M (-63.70%) | -37.05M (+28400.00%) | -130.00K (-13.33%) | -150.00K | 270K | -10.00K | 60K (-66.67%) | 180K (-5.26%) | 190K (+533.33%) | 30K (0.00%) | 30K | -10.00K | 20K |
Net Income | -1.43M | 360K | -5.89M (-66.50%) | -17.58M (+219.06%) | -5.51M (-39.32%) | -9.08M (+460.49%) | -1.62M (-79.49%) | -7.90M (+20.98%) | -6.53M (-33.77%) | -9.86M (+62.71%) | -6.06M (-30.50%) | -8.72M (+58.26%) | -5.51M (-46.19%) | -10.24M (+12.78%) | -9.08M (+30.09%) | -6.98M (-48.10%) | -13.45M (-63.70%) | -37.05M (+28400.00%) | -130.00K (-13.33%) | -150.00K | 270K | -10.00K | 60K (-66.67%) | 180K (-5.26%) | 190K (+533.33%) | 30K (0.00%) | 30K | -10.00K | 20K |
Comprehensive Income Net Of Tax | - | - | -5.89M | - | - | -25.13M (+1441.72%) | -1.63M (-79.37%) | -7.90M (+20.98%) | -6.53M (-78.34%) | -30.15M (+397.52%) | -6.06M (-31.53%) | -8.85M (-19.03%) | -10.93M | - | -9.08M (+30.09%) | -6.98M (-48.10%) | -13.45M | - | - | - | - | - | - | - | - | - | - | - | - |